Development of p53 expressing viral vector using human insulator.
Project/Area Number |
23890046
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Obstetrics and gynecology
|
Research Institution | The University of Tokyo |
Principal Investigator |
MORI Mayuyo 東京大学, 医学部付属病院, 登録研究医 (30570452)
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | p53・インスレーター / インスレーター / ベクター / p53 |
Research Abstract |
Efficient and continuous expression of a therapeutic transgene is a key factor for improving the efficacy of gene therapy. Some insulators are known to contribute to continuous high-level expression of a therapeutic transgene. In this study, we modified an adeno-associated virus serotype 2 (AAV2) vector expressing p53 from the mouse muscle creatine kinase gene promoter-enhancer (Ckm).
|
Report
(3 results)
Research Products
(2 results)